Description: D1ASP0RA (Madison, WI) is a foundry setup in 2016 to form healthcare ventures around disruptive technologies. Focus areas include precision medicine, regenerative medicine, and phenotypic drug discovery. Thus far we have launched four companies that are at various stages of development.
D1ASP0RA (Madison, WI) is a foundry setup in 2016 to form healthcare ventures around disruptive technologies. Focus areas include precision medicine, regenerative medicine, and phenotypic drug discovery. Thus far we have launched four companies that are at various stages of development.
Our portfolio is focused on ventures developing disease-modifying gene and cell therapies. Genetic and anatomical repair of tissues is an emerging approach for treatment of conditions where small molecule or biologic drugs have not succeeded. Correcting the underlying deficit within a cell or tissue can halt and potentially reverse severe disease conditions.
Highlighted Deal - Opsis Therapeutics entered into a Strategic R&D Alliance: